Trastuzumab — Mechanism of Action and Use in Clinical Practice

10.1038/312513a0

Albanell J, 1996, Anticancer Res, 16, 1027

Seidman AD, 2001, J Clin Oncol, 19, 2587, 10.1200/JCO.2001.19.10.2587

Ellis MJ, 2001, J Clin Oncol, 19, 3808, 10.1200/JCO.2001.19.18.3808

Menard S, 2001, J Clin Oncol, 19, 329, 10.1200/JCO.2001.19.2.329

Berry DA, 2000, J Clin Oncol, 18, 3471, 10.1200/JCO.2000.18.20.3471

10.1016/S0959-8049(01)00230-1

10.1038/nature01392

10.1038/sj.onc.1203967

10.1038/35052073

Molina MA, 2001, Cancer Res, 61, 4744

Bargmann CI, 1988, EMBO J, 7, 2043, 10.1002/j.1460-2075.1988.tb03044.x

10.1002/(SICI)1097-0142(19960101)77:1<71::AID-CNCR13>3.0.CO;2-5

10.1126/science.2470152

10.1034/j.1600-0714.2002.00017.x

10.1046/j.1464-410X.2002.02526.x

10.1016/j.ejca.2003.08.027

10.1002/cncr.10339

10.1097/00000421-200110000-00016

10.1007/s10620-005-9057-1

10.1126/science.3798106

Colomer R, 2000, Clin Cancer Res, 6, 2356

Lebeau A, 2001, J Clin Oncol, 19, 354, 10.1200/JCO.2001.19.2.354

10.1200/JCO.2006.09.2775

Valabrega G, 2007, Ann Oncol, 1, 17

10.1016/S1535-6108(04)00088-1

10.1200/JCO.2005.03.184

10.1038/sj.onc.1204000

10.1038/74704

10.1158/1078-0432.CCR-04-0225

10.1200/JCO.2002.06.171

Milenic DE, 2004, Cancer Biol Ther, 3, 361, 10.4161/cbt.3.4.790

Petit AM, 1997, Am J Pathol, 151, 1523

Viloria-Petit A, 2001, Cancer Res, 61, 5090

10.1016/S0093-7754(01)90279-9

Pegram MD, 2002, Semin Oncol, 29, 29, 10.1053/sonc.2002.34053

Fendly BM, 1990, Cancer Res, 50, 1550

10.1007/BF00918679

10.1073/pnas.89.10.4285

Baselga J, 1996, J Clin Oncol, 14, 737, 10.1200/JCO.1996.14.3.737

Cobleigh MA, 1999, J Clin Oncol, 17, 2639, 10.1200/JCO.1999.17.9.2639

10.1200/JCO.20.3.719

10.1200/JCO.2003.12.109

10.1200/JCO.2005.01.014

10.1056/NEJM200103153441101

10.1200/JCO.2005.04.173

10.1200/JCO.2002.07.058

10.1200/JCO.2003.02.018

10.1634/theoncologist.7-5-410

Bangemann N, 2000, Ann Oncol, 11, 143

Theodoulou M, 2002, Proc Am Soc Clin Oncol, 21, 55a

10.1200/JCO.2005.03.8331

10.3816/CBC.2002.s.004

Pegram MD, 1999, Semin Oncol, 26, 89

10.1200/JCO.2005.04.1764

Sledge GW, 2003, Oncology (Williston Park), 17, 33

Bianchi G, 2003, Clin Cancer Res, 9, 5944

10.1093/jnci/djh133

10.3816/CBC.2002.s.006

10.1200/JCO.20.5.1215

10.1016/S0093-7754(01)90278-7

10.1056/NEJMp058315

10.1053/j.seminoncol.2003.08.007

10.1016/S1050-1738(02)00231-1

10.1210/rp.59.1.1

10.1038/nm0502-459

10.1073/pnas.122249299

10.1200/JCO.2004.01.120

10.1002/cncr.10854

Mass RD, 2001, Proc Am Soc Clin Oncol, 20, 22a

Seidman AD, 2004, Proc Am Soc Clin Oncol, 23, 512a, 10.1200/jco.2004.22.14_suppl.512

Mass RD, 2000, Proc Am Soc Clin Oncol, 19, 75a

Jacobs TW, 1999, J Clin Oncol, 17, 1974, 10.1200/JCO.1999.17.7.1974

Jacobs TW, 1999, J Clin Oncol, 17, 1983, 10.1200/JCO.1999.17.7.1983

10.1200/JCO.2005.03.4744

Santinelli A, 2002, Anal Quant Cytol Histol, 24, 54

10.1056/NEJMoa052122

Perez EA, Suman VJ, Davidson N, Martino S, Kaufman P. NCCTG N9831, May 2005 update. Presented at the 45th annual meeting of the American Society of Clinical Oncology, Orlando, FL, May 16, 2005.

10.1016/S0140-6736(07)60028-2

10.1056/NEJMoa053028

Carlson RW, 2006, J Natl Compr Canc Netw, 4, S1, 10.6004/jnccn.2006.0082

10.1093/annonc/mdj963

10.1023/A:1011133908093

10.1038/sj.onc.1202526

10.1158/1078-0432.CCR-03-0463

10.1634/theoncologist.6-4-315

10.1056/NEJMoa064320

Modi S, 2005, Breast Cancer Res Treat, 94, S72

10.1158/1078-0432.CCR-06-1345

10.1056/NEJMoa064320